Abstract
References
- Mc Sweeney LC, Monteith C, Kelliher N, et al. 252: Changing patterns of invasive fetal diagnostic testing in the era of NIPT. AJOG 2018; 218: 162-3.
- Mikwar M, MacFarlane AJ, Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat Res Rev Mutat Res 2020; 785: 108320.
- Bouariu A, Panaitescu AM, Nicolaides KH. First trimester prediction of adverse pregnancy outcomes-identifying pregnancies at risk from as early as 11-13 weeks. Medicina (Kaunas) 2022; 58: 332.
- LeFevre NM, Sundermeyer RL. Fetal aneuploidy: screening and diagnostic testing. Am Fam Physician 2020; 101: 481-8.
- Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-8.
- American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol 2020; 136: 48-69.
- Shahat ARS, Greco G. The economic costs of childhood disability: a literature review. Int J Environ Res Public Health 2021; 18: 3531.
- Karadeniz RS, Altay M, Karasu Y, Gelişen O, Haberal A. Comparison of triple and qadrupple test in second trimester Down syndrome screening. GORM 2009; 15: 4-7.
- Kagan KO, Sonek J, Kozlowski P. Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet 2022; 305: 825-35.
- Canick JA, Kellner LH. First trimester screening for aneuploidy: serum biochemical markers. Semin Perinatol 1999; 23: 359-68.
- Dhillon-Smith RK, Coomarasamy A. TPO antibody positivity and adverse pregnancy outcomes. Best Pract Res Clin Endocrinol Metab 2020; 34: 101433.
- Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001; 30: 315-7.
- Chardès T, Chapal N, Bresson D, et al. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases. Immunogenetics 2002; 54: 141-57.
- Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41: 1149-60.
- Xie J, Jiang L, Sadhukhan A, et al. Effect of antithyroid antibodies on women with recurrent miscarriage: A meta-analysis. Am J Reprod Immunol 2020; 83: e13238.
- Midan MF, Elfayoumy KN, El-Bassiony WM, Al-Metwally AA. Thyroid-stimulating hormone in pregnancy: are we in need of a lower cutoff value? BMFJ 2018; 35: 241.
- Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 2008; 14: 458-64.
- Lata K, Dutta P, Sridhar S, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case–control study. Endocr Connect 2013; 2: 118-24.
- Wang JW, Liao XX, Li T. Thyroid autoimmunity in adverse fertility and pregnancy outcomes: timing of assisted reproductive technology in AITD women. J Transl Int Med 2021; 9: 76-83.
- Gungor K, Dokuzeylul Gungor N. Antithyroid antibodies may predict serum beta HCG levels and biochemical pregnancy losses in euthyroid women with IVF single embryo transfer. Gynecol Endocrinol 2021; 37: 702-5.
- Perminova S. Pathology of the thyroid gland in women with infertility. Klinicheskaya i eksperimental’naya tireoidologiya. 2011; 7: 44-50.
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017; 27: 315-89.
- Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado Hda C, Fernandes A. High prevalence of infertility among women with Graves' disease and Hashimoto's thyroiditis. Int J Endocrinol 2014; 2014: 982705.
- Venables A, Wong W, Way M, Homer HA. Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis. Reprod Biol Endocrinol 2020; 18: 120.
- Wasserman EE, Pillion JP, Duggan A, et al. Childhood IQ, hearing loss, and maternal thyroid autoimmunity in the Baltimore Collaborative Perinatal Project. Pediatr Res 2012; 72: 525-30.
- Wasserman EE, Nelson K, Rose NR, et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 2008; 167: 701-10.
- Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011; 96: 920-4.
- Männistö T, Vääräsmäki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009; 94: 772-9.
- Dokuzeylül Güngör N, Gürbüz T, Erşahin AA. The effects of transfer day in intracytoplasmic sperm injection (ICSI) pregnancies on first trimester screening test results. Adıyaman Üni. Sağlık Bilimleri Derg 2018; 4: 1083-93.
- Dokuzeylül Güngör N, Gürbüz T, Gökmen Karasu AF, Ersahin AA. The alteration of first trimester screening markers in fresh and frozen-thawed blastocyst transfers. EuRj 2019; 5: 686-90.
The findings about relationship between autoimmune thyroid disease and first-trimester aneuploidy results
Abstract
Aim: The aim of this study was to investigate the relationship between thyroid autoantibody and first-trimester aneuploidy results. Thyroid autoimmunity (TAI) is the most common autoimmune disorder. Patients with TAI are usually euthyroid. Thyroid peroxidase (TPO-Ab) in patients with or without thyroid dysfunction is associated with infertility, recurrent embryo implantation failure, and early pregnancy loss. The impact of TPO-Ab on first-trimester aneuploidy test results needs to be studied.
Material and Method: This retrospective case-control study was conducted between December 2019 and May 2022. Patients with thyroid autoantibody positivity (n=112) were included in the study as the case group. The control group was selected from age and body mass index (BMI)-matched patients (n=130). Nuchal translucency (NT), crown rump length (CRL), pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (β-hCG)) values were compared between the two groups.
Results: This study included two hundred forty two age-matched (29.86±4.51) and BMI-matched (23.96±2.34) women. There was no statistically significant difference between groups in terms of free thyroxine (FT4), PAPP-A and free β-hCG (p>0.05). NT as a marker for major chromosomal defects and CRL were comparable in case and control groups (p>0.05).
Conclusion: There is no statistically significant relationship between thyroid autoimmune diseases and the first-trimester aneuploidy results.
Keywords
References
- Mc Sweeney LC, Monteith C, Kelliher N, et al. 252: Changing patterns of invasive fetal diagnostic testing in the era of NIPT. AJOG 2018; 218: 162-3.
- Mikwar M, MacFarlane AJ, Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat Res Rev Mutat Res 2020; 785: 108320.
- Bouariu A, Panaitescu AM, Nicolaides KH. First trimester prediction of adverse pregnancy outcomes-identifying pregnancies at risk from as early as 11-13 weeks. Medicina (Kaunas) 2022; 58: 332.
- LeFevre NM, Sundermeyer RL. Fetal aneuploidy: screening and diagnostic testing. Am Fam Physician 2020; 101: 481-8.
- Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-8.
- American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol 2020; 136: 48-69.
- Shahat ARS, Greco G. The economic costs of childhood disability: a literature review. Int J Environ Res Public Health 2021; 18: 3531.
- Karadeniz RS, Altay M, Karasu Y, Gelişen O, Haberal A. Comparison of triple and qadrupple test in second trimester Down syndrome screening. GORM 2009; 15: 4-7.
- Kagan KO, Sonek J, Kozlowski P. Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet 2022; 305: 825-35.
- Canick JA, Kellner LH. First trimester screening for aneuploidy: serum biochemical markers. Semin Perinatol 1999; 23: 359-68.
- Dhillon-Smith RK, Coomarasamy A. TPO antibody positivity and adverse pregnancy outcomes. Best Pract Res Clin Endocrinol Metab 2020; 34: 101433.
- Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001; 30: 315-7.
- Chardès T, Chapal N, Bresson D, et al. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases. Immunogenetics 2002; 54: 141-57.
- Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41: 1149-60.
- Xie J, Jiang L, Sadhukhan A, et al. Effect of antithyroid antibodies on women with recurrent miscarriage: A meta-analysis. Am J Reprod Immunol 2020; 83: e13238.
- Midan MF, Elfayoumy KN, El-Bassiony WM, Al-Metwally AA. Thyroid-stimulating hormone in pregnancy: are we in need of a lower cutoff value? BMFJ 2018; 35: 241.
- Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 2008; 14: 458-64.
- Lata K, Dutta P, Sridhar S, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case–control study. Endocr Connect 2013; 2: 118-24.
- Wang JW, Liao XX, Li T. Thyroid autoimmunity in adverse fertility and pregnancy outcomes: timing of assisted reproductive technology in AITD women. J Transl Int Med 2021; 9: 76-83.
- Gungor K, Dokuzeylul Gungor N. Antithyroid antibodies may predict serum beta HCG levels and biochemical pregnancy losses in euthyroid women with IVF single embryo transfer. Gynecol Endocrinol 2021; 37: 702-5.
- Perminova S. Pathology of the thyroid gland in women with infertility. Klinicheskaya i eksperimental’naya tireoidologiya. 2011; 7: 44-50.
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017; 27: 315-89.
- Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado Hda C, Fernandes A. High prevalence of infertility among women with Graves' disease and Hashimoto's thyroiditis. Int J Endocrinol 2014; 2014: 982705.
- Venables A, Wong W, Way M, Homer HA. Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis. Reprod Biol Endocrinol 2020; 18: 120.
- Wasserman EE, Pillion JP, Duggan A, et al. Childhood IQ, hearing loss, and maternal thyroid autoimmunity in the Baltimore Collaborative Perinatal Project. Pediatr Res 2012; 72: 525-30.
- Wasserman EE, Nelson K, Rose NR, et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 2008; 167: 701-10.
- Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011; 96: 920-4.
- Männistö T, Vääräsmäki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009; 94: 772-9.
- Dokuzeylül Güngör N, Gürbüz T, Erşahin AA. The effects of transfer day in intracytoplasmic sperm injection (ICSI) pregnancies on first trimester screening test results. Adıyaman Üni. Sağlık Bilimleri Derg 2018; 4: 1083-93.
- Dokuzeylül Güngör N, Gürbüz T, Gökmen Karasu AF, Ersahin AA. The alteration of first trimester screening markers in fresh and frozen-thawed blastocyst transfers. EuRj 2019; 5: 686-90.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | October 25, 2022 |
| Published in Issue | Year 2022 Volume: 5 Issue: 6 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.